has been cited by the following article(s):
[1]
|
Immunomodulation of MiRNA-223-based nanoplatform for targeted therapy in retinopathy of prematurity
Journal of Controlled Release,
2022
DOI:10.1016/j.jconrel.2022.08.006
|
|
|
[2]
|
Immunomodulation of MiRNA-223-based nanoplatform for targeted therapy in retinopathy of prematurity
Journal of Controlled Release,
2022
DOI:10.1016/j.jconrel.2022.08.006
|
|
|
[3]
|
Positron Emission Tomography in the Inflamed Cerebellum: Addressing Novel Targets among G Protein-Coupled Receptors and Immune Receptors
Pharmaceutics,
2020
DOI:10.3390/pharmaceutics12100925
|
|
|
[4]
|
Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
AAPS Advances in the Pharmaceutical Sciences Series,
2019
DOI:10.1007/978-3-030-29168-6_14
|
|
|